Health & Medicine PD1 & PD L1 Targeted Agents - Nivolumab Clinical & Commercial Development (110113)

1. Source:    Depiction  courtesy  of  Genentech  By  Will  Roettger   Principal  Consultant  20/20  Market  Insights,  LLC   November  3,  2013   2. Page…